
sensitiveéãããããããŸããã···
1ã
 ãããšããšç§ã¯ä»äººãšã¯å¯èœãªéããç©ççã瀟äŒçã«è·é¢ããããŠããããæ¹ã ã£ãã
ãæ©ããŠãããšãã§ãããååŸïŒm以å
ã«äººããããšäžå¿«ã«æãããã ãããéœåžéšã§ã¯æ¥µååšå²ãæ°ã«ããªãããã«æ©ããŠãããã«ãã§ãšãã人ãå€ãããæŒ«å«ãå¯éæãèŠçãªã®ã§(ãããèãã)ãæ¯èŒç倧ããæ¬å±ã®å¥¥ã®æ¹ã®å°éæžã³ãŒããŒãªã©æ¬ãšèªåã ãã«ãªãã空éã«é¿é£ããããä»ã¯ãã£ããæžã£ãŠããŸã£ãCDå±ã§ã²ããã詊èŽãããããŠæ°å転æããŠããã
ãã ãããç°èã®ã誰ãããªãå Žæãäžäººãµããµããšæ©ãã®ã奜ãã ã£ãã
ãã§ããããã¯ãã§ã¹ãéç芳æŠã«ã¯æã
è¡ã£ããåºæ¬äžäººã§ãçŽç²ã«çé³ãç±æ°ãæããããã ãã«è¡ã£ãŠãããåããã®ã奜ããªäººã
ã®äžã«åãããŠããããšã¯ãããŸãèŠçã§ã¯ãªãã£ãããã ã
ã
ãç«å Žäžããšãããèœåçã«åŠäŒã«ããçšåºŠäŸåããããåŸãªãã®ã§ãç·äŒãå°æ¹äŒãªã©ã«çŸå°åå ããªããã°ãªããªãã£ãã
ããã®éã¯å身ã§äŒå Žã«èµŽããåºæ¥ãéãäžéå端ãªç¥ãåãã«å£°ãããããã¬ããã«æ³šæãæã£ãŠããããã¡ããç¥ãåãã«äŒãã°æ®éã«äº€æµã¯ããããç«ã¡è©±ãŸã§ã«æžãŸããŠããããŸããŠãé£ãã ã£ãŠåå ããŠãã人éã®æ°ãç¥ããªãã£ãããããã§ãè¬æŒãã¬ã¯ãã£ãŒã«éäžã§ããããã ããã¹ã¿ãŒçºè¡šã®äŒå Žã«ã¯ãã©ãããŠãè¶³ãé ã®ããŠããã
ãã ãããæè¿ã®webåå å¶ã¯ãããããããã£ãšãæè¿ã¯ãå°éå»ç¶æã«å¿
èŠãªåäœãéã§è²·ã£ãŠããæãã¯åŠããªãããã©ã
ã
ãåœç¶ã飲ã¿äŒãäŒé£ã¯èŠçã ã£ããè¥ãããã¯ãæ°å¿ç¥ãã人ã
ãšã§ããã°åé¡ãªãã£ãããããæ°å¹Žã¯ãããããèŠçã ã£ããäœãããçã空éã«ä»äººã©ãããåãåã£ãŠå¯éããŠããç¶æ³ãææ
¢ãªããªããèãããããããäœãæ²ãããŠä»äººã®é¢ãèŠãªãããã©ãã§ããã話ã«çžæ§ãæã¡ãªããã飯ãé£ããã°ãªããªãã®ã ã飯ã®å³ã«éäžã§ããªãã§ã¯ãªããã
ããªã®ã§ãè¿å¹Žã¯åäŸããããšããåãããããçç±ãå©çšããŠã極ååå ããªãããã«ããŠããã
ã
ãåœçŽå®€ãªã©ãå¯éãããéšå±ã«å
¥ããããåŸãªãæã¯ããŸãæåã«çªãå
šéã«ããŠç©ºæ°ãå
¥ãæããããã«ããŠããã倿°ã«è§ŠããŠããªããšé ãéããªã鬱ã
ãšããŠããŸãã®ã ããªãå€ãã®äººã¯çªãéããããšããªãã®ãããã£ãšäžæè°ã ã£ããå€ã®ç©ºæ°ã®æ¹ãããããªã®ã«ã空æ°ã埪ç°ãããæ¹ãæ°æã¡ããã®ã«ã
ãã€ãŸããããšããšç§ã«ãšã£ãŠãããããïŒå¯ç©ºéã¯äžå¿«ãã®ãã®ã ã£ãããããè§£æ¶ããã瀟äŒã¯ããã®ç¹ã«ãããŠã¯ãç§ã«ãšã£ãŠå¿«é©ã ã£ãã®ã¯ééããªãã
2
ããªã³ã©ã€ã³ã§æžãŸãããšãã§ããäŒåãå¢ããã®ããå¿«é©ã ã£ããé¡ãçªãåãããç©ºæ°æå
±æããªããã°ãªããªãã®ã¯ãçå£åè² ã®æã ãã§ãããèªåã«ãšã£ãŠã¯èšåºã®çŸå Žãããã®æã ã
ãç©ºæ°æãå
±æããããšã¯å€§äºã ãèšèªã«ãå£èª¿ã«ã衚æ
ã«ãåºãªãææ
ã¯ãééããªããããããã®ææ
ãçžäºçè§£ã«ãšã£ãŠçµæ§å€§äºãªãã®ã ããã ãç¹ã«é«éœ¢è
ã¯ããã ãããããŠå€ååäŸãããã ãããé·ãä»ãåãã®æ£è
ãªãããããããã衚é¢ã«åºããŠãããããããªã³ã©ã€ã³èšºçã¯å¯èœã ãããã§ãããããäœåãç¶ããšãæ°ã¥ãã¬ãã¡ã«éœéœ¬ãçãŸããããã«æãã
ãã ãããªã³ã©ã€ã³èšºçã®äœ¿çšã¯éå®çãªã±ãŒã¹ã«çããã¹ãã ãšèããŠããã
ãã§ãããã以å€ã¯ãªã³ã©ã€ã³ã§ããã
3ã
 ãããšããšä»äºæãææŽããããã®ç¿æ
£ã¯ãã£ããã¢ã«ã³ãŒã«æ¶æ¯ã¯ç®èã«ãã¡ãŒãžäžããã®ã§æå°éã«æããŠããããã©ã
ãæ ç»é€šãªã©ã®å¯ããŠç©ºæ°ã®ä¹Ÿç¥ã匷ãå Žæã§ã¯ãåãçããªãæ¯èŠãããªãã®ã§ãã¹ã¯ã䜿çšããŠããã
ãå¬ã®ãã¹ã®äžãªã©ææ¿äœ¿çšããå¯é空éã§ã¯ã空æ°ãæ·ãã§ããæããããŠãä»äººã®åããæ¯ãæ°ã«ãªã(ãšãããä»äººã®èããããŸããªãäžå¿«ãªã®ã§)ãã¹ã¯ãããŠããã
ãåœç¶ä»äºæããã¹ã¯ã¯ãã䜿çšããŠããã
ããã¡ããããã»ã©å¯ããªãéãå±å€ã§äœ¿çšããã®ã¯ãã³ã»ã³ã¹ã®æ¥µã¿ã ããæ©ç§ïœæ©æ¥ã«ãããŠå±å
ã§ãã¹ã¯ã䜿çšããããšã¯ãèªèº«ã®ç¿æ
£ãšããŠç¢ºç«ããŠããã
ããªã®ã§ãèªåèªèº«ã®ããšã ãèããã®ãªãã°ãéå°ãªææå¯Ÿçã«å¯ŸããŠããããŸãæµæãæããã«åãããããšãã§ããã®ãããããªãã
ã SARS CoV 2èªäœããåæã®äžåœã®ããŒã¿ãèŠãéããå°ãªããšãæ¬å®¶ã®SARS CoVã»ã©èŠæããå¿
èŠã¯ãªãããšã¯åæã®é ããåãã£ãŠããã
ããããããæããæ±ã¢ãžã¢ã¯ã³ãããŠã€ã«ã¹ãšå
±çããŠãã®ã ããããããªã«æããå¿
èŠã¯ãªãã ããããšæã£ãŠããã
ããªã®ã§ãå人çã«ã¯COVID 19ã«ææãæããããšã¯ããã®3幎éäžåºŠããªãã£ããããèºçã«ãªã£ãŠããŸã£ããããã»ã©æŽé²æã«äœèª¿ãæªãã£ãã®ã ãããšèããããããéçåãããããããéåœã ã£ãããšããããããããªããšæã£ãŠããã
ãããšãä»äºæãæ»ã«åããæ¹ã
ãšæ¥ããããšãããã®æ¹ã
ãçåãããšãæ¥åžžçã«è¡ã£ãŠããã®ã§ãæ»ã¯èº«è¿ãªãã®ã ã£ããæã身ã«çœ®ãæããŠèªèº«ãè¿èŠªè
ã®ææã«ã€ããŠæãã銳ããæ©äŒãå€ãã£ãã
ãã¯ã¯ãã³æ¥çš®ããä»è
ã®ç®ãæ°ã«ããªããã°ãæåŠããããšã«é¢ããŠã¯ç¹ã«æ¯éã¯ãªãç«å Žã ã£ãããŸããããã¯æ¬æ¥ã§ããã°ãç«å Žã«é¢ãããåœããåã®ããšã ã£ãã®ã ãã
4
ããã®ããã«èãããšãç§äžäººã ãã§è¡åãçããŠããããšã ããèããã°ãèªåããã®3幎éã«äžå¿«æãèŠçãæããçç±ã¯å°ãªããããã以åããå±
å¿å°ãããã¯ãã ã£ãã
ã
ãããããã®3幎éãç§ã¯éåžžã«å±
å¿å°ãæªãã£ãã
ãä»ãŸã§ä¿¡é ŒããŠãã人ã
ã®è¡åãæèã«å¯ŸããŠãçåãå°œããªãã£ããæ€ããæããããšãããŸãã«ãå€ãã£ãã
ãå°çª®ããŠããæ¹ã
ã®å§¿ãèŠãã®ãèŸãã£ãã
ãå
ç«¥ãåŠçããããæè²ãåããæš©å©ãããå¥åº·ã«è²æãããæš©å©ããå¹³æ°ã§å¥å¥ªãã倧人ãã¡ã®å§¿ã¯ãæ³åãçµ¶ããŠããã
ããããŠã人ã
ã®å°çª®ã«åæ¥è
ãæ·±ãé¢ããããŸãã«å»åæ§ã³ãã察ççŠãç£ã¿åºãç¶ããŠããå§¿ã«ãç§ã®äŸ¡å€èгã¯å€§ããæºããããããããã«ã¯ã¯ãã³çŠãšããé眪ãŸã§å ãã£ãŠããŸã£ãã
ãããå°ãéæã«ãªãã¹ããªã®ãããããªãããç§ã«ãšã£ãŠã¯ããããã£ãšãé£ãããåŠã³ãæ·±ããè¯ãæ©äŒã«ã¯ãªã£ãããã©ã